News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,810 Results
Type
Article (13741)
Company Profile (101)
Press Release (250968)
Section
Business (88030)
Career Advice (465)
Deals (15342)
Drug Delivery (66)
Drug Development (36590)
Employer Resources (49)
FDA (6286)
Job Trends (6195)
News (150184)
Policy (14023)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (30)
Alliances (23211)
ALS (35)
Alzheimer's disease (380)
Antibody-drug conjugate (ADC) (35)
Approvals (6316)
Artificial intelligence (98)
Autoimmune disease (7)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (52)
Biotechnology (40)
Bladder cancer (17)
Brain cancer (15)
Breast cancer (74)
Cancer (553)
Cardiovascular disease (62)
Career advice (407)
Career pathing (11)
CAR-T (19)
Cell therapy (79)
Cervical cancer (4)
Clinical research (30828)
Collaboration (310)
Compensation (131)
Complete response letters (16)
COVID-19 (757)
CRISPR (19)
C-suite (106)
Cystic fibrosis (35)
Data (560)
Denatured (15)
Depression (9)
Diabetes (74)
Diagnostics (1312)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (53)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (31)
Earnings (31987)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37335)
Executive appointments (345)
FDA (6655)
Featured Employer (20)
Friedreich's ataxia (2)
Funding (196)
Gene editing (37)
Generative AI (8)
Gene therapy (97)
GLP-1 (331)
Government (1283)
Grass and pollen (2)
Guidances (15)
Healthcare (3561)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (31)
Indications (12)
Infectious disease (788)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (39)
Interviews (59)
IPO (5874)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (9)
Layoffs (176)
Leadership (3)
Legal (3429)
Liver cancer (19)
Lung cancer (75)
Lymphoma (50)
Machine learning (1)
Management (16)
Manufacturing (135)
MASH (29)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (9645)
Metabolic disorders (236)
Multiple sclerosis (16)
NASH (14)
Neurodegenerative disease (20)
Neuropsychiatric disorders (5)
Neuroscience (537)
NextGen: Class of 2025 (1585)
Non-profit (593)
Northern California (649)
Now hiring (7)
Obesity (136)
Opinion (117)
Ovarian cancer (19)
Pain (49)
Pancreatic cancer (13)
Parkinson's disease (41)
Partnered (5)
Patents (99)
Patient recruitment (27)
Peanut (9)
People (28828)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8025)
Phase II (13044)
Phase III (11701)
Pipeline (343)
Podcasts (45)
Policy (57)
Postmarket research (1401)
Preclinical (3199)
Press Release (25)
Prostate cancer (43)
Psychedelics (8)
Radiopharmaceuticals (119)
Rare diseases (155)
Real estate (2633)
Recruiting (17)
Regulatory (10047)
Reports (13)
Research institute (563)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (32)
Series A (33)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (665)
Special edition (6)
Spinal muscular atrophy (76)
Sponsored (6)
Startups (1626)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6614)
Vaccines (146)
Venture capitalists (13)
Webinars (10)
Weight loss (92)
Women's health (8)
Worklife (3)
Date
Today (20)
Last 7 days (212)
Last 30 days (1030)
Last 365 days (12162)
2025 (2671)
2024 (12500)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (50)
Arkansas (3)
Asia (20053)
Australia (2601)
California (1579)
Canada (853)
China (207)
Colorado (63)
Connecticut (65)
Delaware (51)
Europe (39292)
Florida (293)
Georgia (34)
Idaho (9)
Illinois (179)
India (13)
Indiana (125)
Iowa (1)
Japan (80)
Kansas (54)
Kentucky (12)
Maine (2)
Maryland (242)
Massachusetts (1355)
Michigan (27)
Minnesota (88)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (685)
New Mexico (7)
New York (461)
North Carolina (370)
North Dakota (2)
Northern California (649)
Ohio (46)
Oklahoma (4)
Oregon (16)
Pennsylvania (397)
Puerto Rico (8)
Rhode Island (6)
South America (501)
South Carolina (2)
Southern California (665)
Tennessee (33)
Texas (208)
Utah (33)
Virginia (68)
Washington D.C. (29)
Washington State (109)
Wisconsin (14)
264,810 Results for "aprecia pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Aprecia and Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation
Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing platforms with the potential to transform the way medicines are developed, manufactured, distributed, and administered.
November 15, 2023
·
4 min read
Business
Aprecia Names Industry Leader Owen Murray as Its CEO
Aprecia Pharmaceuticals today announced Owen Murray as its Chief Executive Officer.
January 30, 2023
·
2 min read
Business
Aprecia Selects Garry Hedgepeth to Lead Quality Team
Aprecia Pharmaceuticals announced that it has hired Garry Hedgepeth as Vice President of Quality.
March 8, 2022
·
2 min read
BioMidwest
Glatt Pharmaceutical Services and Aprecia to Advance Patient Focused Pharmaceuticals with Aprecia’s 3D-Printing Technology
Glatt Pharmaceutical Services and Aprecia announce their joint effort to accelerate and expand the use of Glatt’s multiparticulate technologies through Aprecia’s 3DP manufacturing
February 23, 2021
·
3 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
BioMidwest
Purdue University Receives 3DP Equipment from Aprecia Pharmaceuticals
Purdue University continues to make giant leaps in innovation with the recent 3D printing (3DP) equipment donation from its industry partner Aprecia Pharmaceuticals.
November 18, 2020
·
2 min read
Business
Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.
April 21, 2021
·
5 min read
Business
Aprecia Establishes a Long-Term Partnership with Battelle
Battelle’s innovative design teams will focus on expanding the capabilities of Aprecia’s 3DP technology platform addressing important pharmaceutical product challenges through 3DP innovation
December 21, 2020
·
2 min read
Business
Aprecia Appoints Kathi Rinesmith Senior Vice President, Regulatory Affairs
Aprecia, the 3DP Pharmaceutical Company, today announced the appointment of Kathi Rinesmith, R.Ph., MS as Senior Vice President of Regulatory Affairs.
September 16, 2020
·
2 min read
1 of 26,481
Next
